Goldman Sachs Boosts Price Target on Intuitive Surgical (ISRG), But Keeps Neutral Rating

Goldman Sachs lifted its price target on Intuitive Surgical (NASDAQ: ISRG) from $576 to $604 but kept its Neutral rating following strong Q1 results after the close.

The firm notes both system placements and procedure volumes continue to surprise to the upside. While trends in Europe remain weak, the U.S. and the rest of the world continue to see strength. Also, the company continue to grow the "other" procedure category. This said, the firm sees limited upside to guidance unless the operating environment in Europe improves or if there is a sharp inflection point in new product adoption.

For an analyst ratings summary and ratings history on Intuitive Surgical click here. For more ratings news on Intuitive Surgical click here.

Shares of Intuitive Surgical closed at $545.53 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
• Okta, Inc (OKTA) PT Raised to $170 at Cantor Fitzgerald Ahead of Q2 Results
• Rubrik Inc (RBRK) PT Raised to $120 at Cantor Fitzgerald Into Q2 Earnings